MYC-ATF4-ASS1 axis governs intracellular arginine synthesis and dictates the immune microenvironment in melanoma

Haiwei Mou1, Veronika Yakovishina1, Yeqing Chen1

  • 1Melanoma Research Center, Molecular and Cellular Biology Program, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104.

Insights

MYC-ATF4-ASS1 signaling controls melanoma

Area of Science:

  • Oncology
  • Cancer Immunology
  • Molecular Biology

Background:

  • Drug resistance in cancer limits targeted and immunotherapy efficacy.
  • Arginine starvation is a potential strategy against recurrent tumors, but underlying mechanisms and immune modulation are unclear.

Purpose of the Study:

  • To identify key molecules in arginine metabolism and their role in melanoma's immune response.
  • To investigate the MYC-ATF4-ASS1 pathway's function in melanoma cell arginine synthesis and immune modulation.

Main Methods:

  • Utilized ATF4 knockout and Argininosuccinate Synthetase 1 (ASS1) knockout in melanoma cells.
  • Employed a combination therapy of BRAF/MEK inhibitors and an arginine depletor in immunocompromised mice.
  • Conducted experiments in syngeneic mouse models with knockout melanomas.
  • Performed single-cell transcriptomics to analyze the tumor microenvironment.

Main Results:

  • ATF4 knockout mirrored ASS1 knockout, increasing sensitivity to arginine depletors like ADI-PEG20.
  • Combined BRAF/MEK inhibitors and arginine depletion showed therapeutic effects in mice.
  • Atf4 and Ass1 knockout melanomas displayed increased CD8+ T cell infiltration and reduced tumor growth.
  • Single-cell transcriptomics revealed macrophage reprogramming due to endogenous arginine blockade.

Conclusions:

  • The MYC-ATF4-ASS1 axis regulates melanoma's arginine synthesis and vulnerability.
  • This pathway significantly shapes the tumor immune microenvironment, influencing T cell infiltration and macrophage activity.
  • Targeting this axis offers a novel strategy for overcoming drug resistance and enhancing anti-tumor immunity.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.1K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.2K